Refractory chronic inflammatory bowel disease in childhood and adolescence

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Combination biologic therapy in pediatric inflammatory bowel disease: Safety and efficacy over a minimum 12‐month follow‐up period2024 · 15 citations
2. 2Tofacitinib in Pediatric Ulcerative Colitis: A Retrospective Multicenter Experience2024 · 27 citations
3. 3Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials2017 · 371 citations
4. 4Inflammatory bowel disease and Clostridium difficile infection: clinical presentation, diagnosis, and management2023 · 28 citations
5. 5Ustekinumab for the treatment of moderate‐to‐severe plaque psoriasis in paediatric patients (≥ 6 to < 12 years of age): efficacy, safety, pharmacokinetic and biomarker results from the open‐label CADMUS Jr study2020 · 84 citations